Back

Monkeypox virus pangenomics reveals determinants of clade Ib

Sganzerla Martinez, G.; Kumar, A.; Kinganda Lusamaki, E.; Dutt, M.; Wawina-Bokalanga, T.; Toloue Ostadgavahi, A.; Muyembe, F.; Makangara-Cigolo, J.-C.; Kelvin, P.; Amuri Aziza, A.; Richardson, C. D.; Lokilo, E.; Luakanda, G.; Ayouba, A.; Rimoin, A. W.; Mukadi-Bamuleka, D.; Delaporte, E.; Pilarowski, G.; Kindrachuk, J.; Liesenborghs, L.; Hensley, L. E.; Subissi, L.; Peeters, M.; Hoff, N. A.; Tshiani-Mbaya, O.; Tessema, S.; Muyembe, J.-J. T.; Ahuka Mundeke, S.; Kelvin, A.; Archibald, J. M.; Placide, M.; Flores-Giron, L.; Kelvin, D. J.

2024-11-02 infectious diseases Community evaluation
10.1101/2024.10.31.24315917 medRxiv
Show abstract

Mpox, formerly monkeypox, is a viral zoonotic disease caused by the mpox virus (MPXV). MPXV, which is phylogenetically divided into Clades I and II, was declared a Public Health Emergency of International Concern for the second time in August 2024 due to rapid geographic expansion of Clade I viruses including the newly identified subclade Ib. With a unique set of genomic mutations and sustained human-to-human transmission, subclade Ib has rapidly spread throughout the eastern Democratic Republic of the Congo as well as neighboring non-endemic regions and outside the African continent. Currently, there is a lack of comparative genomic data with which to address the potential zoonotic transmissibility and pathobiology of subclade Ib. Here we report 105 protein-coding genes that are shared by all the queried MPXV subclade Ia, Ib, and IIb genomes. Our comparative genomic analysis identified that the core Clade I gene pair, OPG032 and OPG033, is now a critical branching element for subclade Ia/Ib due to their loss in subclade Ib. These genes encode the complement control protein (a vaccinia virus ortholog associated with virulence), and a Kelch-like protein associated with pathogenesis, respectively, suggesting a functional evolution that might play an important role in the pathobiology of the new MPXV subclade Ib. Our results lay the groundwork to exploit the genomic elements of MPXV as potential targets for therapeutics development/repurposing, vaccine design, and molecular diagnostic expansion, as well as to uncover the viral diversity, and human-to-human transmission of MPXV.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Archives of Virology
15 papers in training set
Top 0.1%
30.9%
2
Viruses
332 papers in training set
Top 0.5%
7.8%
3
Virus Evolution
155 papers in training set
Top 0.4%
5.4%
4
PLOS Pathogens
820 papers in training set
Top 3%
4.3%
5
Journal of Medical Virology
140 papers in training set
Top 0.5%
4.3%
50% of probability mass above
6
Vaccines
198 papers in training set
Top 0.9%
3.4%
7
Virology Journal
32 papers in training set
Top 0.1%
3.2%
8
Pathogens
56 papers in training set
Top 0.4%
2.1%
9
PLOS Neglected Tropical Diseases
466 papers in training set
Top 3%
1.9%
10
Microbiology Spectrum
469 papers in training set
Top 6%
1.9%
11
PLOS ONE
5266 papers in training set
Top 48%
1.7%
12
Scientific Reports
3612 papers in training set
Top 56%
1.7%
13
Eurosurveillance
83 papers in training set
Top 0.7%
1.1%
14
Journal of Clinical Virology
63 papers in training set
Top 0.6%
1.1%
15
Virologica Sinica
11 papers in training set
Top 0.1%
1.1%
16
Emerging Microbes & Infections
74 papers in training set
Top 0.9%
1.1%
17
Virology
61 papers in training set
Top 1%
1.0%
18
Microorganisms
106 papers in training set
Top 3%
1.0%
19
The Journal of Infectious Diseases
202 papers in training set
Top 3%
1.0%
20
Nature Communications
5641 papers in training set
Top 54%
1.0%
21
Frontiers in Microbiology
427 papers in training set
Top 8%
0.8%
22
Journal of General Virology
53 papers in training set
Top 0.9%
0.8%
23
iScience
1154 papers in training set
Top 35%
0.8%
24
Frontiers in Immunology
638 papers in training set
Top 10%
0.8%
25
Microbial Genomics
225 papers in training set
Top 2%
0.8%
26
Journal of Clinical Virology Plus
10 papers in training set
Top 0.1%
0.8%